Accenture (ACN)
(Real Time Quote from BATS)
$355.48 USD
-5.23 (-1.45%)
Updated Nov 8, 2024 03:54 PM ET
After-Market: $355.57 +0.09 (0.03%) 4:16 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$355.48 USD
-5.23 (-1.45%)
Updated Nov 8, 2024 03:54 PM ET
After-Market: $355.57 +0.09 (0.03%) 4:16 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
High Demand and Acquisitions Bode Well for Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) reaps the benefits of its solid acquisition strategy amid integration risks.
The Zacks Analyst Blog Highlights Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services
by Zacks Equity Research
Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services are part of the Zacks top Analyst Blog.
5 Stocks in Focus Amid Recent Turmoil in Crypto Market
by Nalak Das
We narrowed our search to five stocks as the cryptocurrency market is facing turmoil in August. These are: HOOD, SQ, PYPL, ACN, IBKR.
Top Research Reports for Accenture, Elevance Health & Analog Devices
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), Elevance Health, Inc. (ELV) and Analog Devices, Inc. (ADI).
CRAI or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. ACN: Which Stock Is the Better Value Option?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Accenture (ACN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Accenture (ACN) closed at $307.40 in the latest trading session, marking a -1.38% move from the prior day.
Accenture (ACN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Accenture (ACN) closed at $311.53 in the latest trading session, marking a -1.15% move from the prior day.
3 Stocks to Watch as Ethereum Builds Base on PayPal Boost
by Abhinab Dasgupta
Accenture (ACN), CME Group (CME) and Cisco (CSCO) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival continues to rise in 2023.
The Zacks Analyst Blog Highlights PayPal, Coinbase Global, NVIDIA and Accenture
by Zacks Equity Research
PayPal, Coinbase Global, NVIDIA and Accenture are part of the Zacks top Analyst Blog.
4 Crypto Stocks to Watch as Fed Seems Open to More Rate Hikes
by Ritujay Ghosh
More rate hikes could adversely impact the crypto market. Investors should thus adopt a buy-on-the-dip strategy, which could help stocks like PayPal Holdings (PYPL), Coinbase Global (COIN), NVIDIA Corporation (NVDA) and Accenture (ACN).
5 Crypto Stocks in Focus After Fed's Rate Hike Reinitiation
by Nalak Das
We have narrowed our search to five stocks with solid crypto exposure. These Are: NVDA, PYPL, SQ, ACN, IBKR.
Sherwin-Williams and Cracker Barrel have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sherwin-Williams and Cracker Barrel have been highlighted as Zacks Bull and Bear of the Day.
3 Crypto Stocks to Watch in the 2023 Ethereum Rally
by Abhinab Dasgupta
Accenture (ACN), CME Group (CME) and HIVE Digital (HIVE) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival continues to rise in 2023.
Is ProShares S&P Technology Dividend Aristocrats ETF (TDV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for TDV
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
by Zacks Equity Research
Sector ETF report for IYJ
Beat the Market the Zacks Way: Adobe, Accenture, Vertiv in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Strategic Enhancements Aid Accenture (ACN) Amid Competition
by Zacks Equity Research
Accenture is experiencing growth in outsourcing and consulting, driven by demand for efficient, cost-saving services. Intense competition poses threats to company???s pricing.
The Zacks Analyst Blog Highlights Mastercard, Oracle, Adobe, Accenture and Qualcomm
by Zacks Equity Research
Mastercard, Oracle, Adobe, Accenture and Qualcomm are part of the Zacks top Analyst Blog.
Top Stock Reports for Mastercard, Oracle & Adobe
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), Oracle Corporation (ORCL) and Adobe Inc. (ADBE).
Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDVY
Accenture (ACN) Surpasses Q3 Earnings Estimates, Rises Y/Y
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2023 results reflect year-over-year growth in earnings and revenues.
Accenture (ACN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 7.77% and 0.41%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) Rises 25% in Three Months: Here's What to Know
by Zacks Equity Research
Accenture (ACN) gains from improved segmental performance.
Here's What to Expect From Accenture's (ACN) Q3 Earnings
by Zacks Equity Research
Growing segmental performance mixed with favorable demand and utilization situation are expected to benefit Accenture (ACN) in the third quarter of fiscal 2023.